rood blauwe elepsis logo Belegger.nl
Aandeel

Genmab A/S DK0010272202

Laatste koers (dkk)

1.225,000
  • Verschil

    +8,000 +0,66%
  • Volume

    220.795 Gem. (3M) 170,6K
  • Bied

    -  
  • Laat

    -  
+ In watchlist

Koers historie

Koershistorie

Interval Verschil in Verschil %
Maand -165,000DKK -11,94 %
Kwartaal -390,500DKK -24,29 %
Halfjaar -387,000DKK -24,13 %
Jaar -846,000DKK -41,01 %
2 Jaar -1.437,000DKK -54,14 %
Datum Open Laag Hoog Slot Volume Verschil Verschil %
03 mrt 2025 1.626,000 1.620,500 1.661,000 1.635,000 120.006 +26,500 +1,65%
04 mrt 2025 1.635,000 1.621,500 1.643,000 1.642,000 125.739 +7,000 +0,43%
05 mrt 2025 1.642,000 1.642,000 1.667,000 1.654,500 120.701 +12,500 +0,76%
06 mrt 2025 1.662,000 1.626,000 1.672,500 1.641,000 104.433 -13,500 -0,82%
07 mrt 2025 1.636,000 1.631,000 1.665,000 1.659,500 110.402 +18,500 +1,13%
10 mrt 2025 1.654,000 1.487,000 1.664,500 1.522,000 552.736 -137,500 -8,29%
11 mrt 2025 1.517,000 1.363,000 1.530,000 1.382,000 492.362 -140,000 -9,20%
12 mrt 2025 1.389,000 1.356,500 1.397,000 1.372,500 219.535 -9,500 -0,69%
13 mrt 2025 1.372,500 1.352,500 1.388,000 1.367,000 162.784 -5,500 -0,40%
14 mrt 2025 1.372,000 1.367,500 1.446,000 1.414,000 239.572 +47,000 +3,44%
17 mrt 2025 1.377,000 1.367,000 1.404,000 1.399,500 179.976 -14,500 -1,03%
18 mrt 2025 1.426,000 1.388,500 1.430,500 1.389,000 153.117 -10,500 -0,75%
19 mrt 2025 1.367,500 1.357,500 1.387,000 1.377,500 178.002 -11,500 -0,83%
20 mrt 2025 1.377,500 1.357,000 1.383,000 1.371,500 109.580 -6,000 -0,44%
21 mrt 2025 1.360,000 1.353,000 1.377,000 1.363,500 145.931 -8,000 -0,58%
24 mrt 2025 1.348,000 1.300,000 1.348,000 1.325,000 245.272 -38,500 -2,82%
25 mrt 2025 1.343,000 1.320,500 1.358,500 1.322,000 108.687 -3,000 -0,23%
26 mrt 2025 1.354,000 1.327,000 1.374,500 1.356,000 224.718 +34,000 +2,57%
27 mrt 2025 1.358,500 1.335,500 1.409,000 1.399,000 230.633 +43,000 +3,17%
28 mrt 2025 1.390,000 1.360,500 1.400,500 1.364,000 194.435 -35,000 -2,50%
31 mrt 2025 1.350,000 1.331,000 1.352,500 1.340,000 217.604 -24,000 -1,76%
IEX Premium

Dit biotechfonds groeit stevig, maar beleggers zijn sceptisch